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Although chorioamnionitis (CA) is a well-known risk factor for white matter disease
of prematurity, the association with intraventricular hemorrhage (IVH) is controversial
and has not been yet systematically reviewed. We performed a systematic review
and meta-analysis of studies exploring the association between CA and IVH. A
comprehensive literature search was conducted using PubMed/MEDLINE and EMBASE,
from their inception to 1 July 2017. Studies were included if they examined preterm
infants and reported primary data that could be used to measure the association
between exposure to CA and the presence of IVH. A random-effects model was used to
calculate odds ratios (OR) and 95% confidence intervals (CI). We found 1,284 potentially
relevant studies, of which 85 met the inclusion criteria (46,244 infants, 13,432 CA cases).
Meta-analysis showed that CA exposure was significantly associated with all grades IVH
(OR 1.88, 95% CI 1.61–2.19), with grades 1–2 IVH (OR 1.69, 95% CI 1.22–2.34), and
with grades 3–4 IVH (OR 1.62, 95% CI 1.42–1.85). Both clinical and histological CA
were associated with an increased risk for developing IVH in very preterm infants. In
contrast, the presence of funisitis did not increase IVH risk when compared to CA in
the absence of funisitis (OR 1.22, 95% CI 0.89–1.67). Further meta-analyses confirmed
earlier findings that CA-exposed infants have significantly lower gestational age (GA;
mean difference [MD] −1.20 weeks) and lower birth weight (BW; MD −55 g) than the
infants not exposed to CA. However, meta-regression and subgroup analysis could
not demonstrate an association between the lower GA and BW and the risk of IVH
in the CA-exposed infants. In conclusion, our data show that CA is a risk factor for
IVH, but also a risk factor for greater prematurity and more clinical instability. In contrast
to other complications of prematurity, such as patent ductus arteriosus, retinopathy of
prematurity, or bronchopulmonary dysplasia, the effect of CA on IVH appears to be
independent of CA as causative factor for very preterm birth.
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INTRODUCTION
Germinal matrix hemorrhage–intraventricular hemorrhage
(GMH-IVH) is one of the most common complications of
prematurity (Ballabh, 2010; Volpe, 2015; Inder et al., 2018).
IVH typically initiates in the germinal matrix, which is a richly
vascularized collection of neuronal-glial precursor cells in the
developing brain and may disrupt the ependymal lining and
extend into the lateral ventricle (Ballabh, 2010; Volpe, 2015;
Inder et al., 2018). Severe IVH (grade 3–4) is associated with
increased mortality as well as short- and long-term neurological
morbidity, whilst the short-term and long-term outcomes of
milder forms of IVH (grade 1–2) are less established, and they
remain a significant research area (Volpe, 2015; Tortora et al.,
2017; Inder et al., 2018).
As extensively reviewed by Inder et al. (2018) the pathogenesis
of IVH is multifactorial and may involve intravascular,
vascular, and extravascular factors. Intravascular factors relate
to the regulation of blood flow, pressure, and volume in
the microvascular bed of the germinal matrix as well as
to platelet-capillary function and blood clotting capability
(Inder et al., 2018). Vascular factors refer to the intrinsic
fragility and vulnerability of germinal matrix blood vessels
(Inder et al., 2018). Extravascular factors include the poor
support of the extravascular space surrounding the germinal
matrix capillaries, the postnatal decrease in extravascular
tissue pressure, and an excessive fibrinolytic activity (Inder
et al., 2018). As assessed by Inder et al. (2018) not all the
pathogenetic factors are present in every IVH and the clinical
circumstances determine which factors are most relevant in
each infant. Among these clinical circumstances, very preterm
birth, generally defined as birth before 32 completed weeks
of gestation, is the most consistently associated with the
development of IVH. However, a number of risk factors
including, among others, absent antenatal corticosteroid (ACS)
treatment, vaginal delivery, peri- and postnatal hypoxic-
ischemic events, severe respiratory distress syndrome (RDS),
pneumothorax, hypercapnia, hemodynamic disturbances (either
systemic hypertension or hypotension), rapid volume expansion,
decreased hematocrit, glucose and/or electrolyte disturbances,
seizures, patent ductus arteriosus (PDA), thrombocytopenia,
inherited thrombophilia, and infection may predispose to the
development of IVH (Ballabh, 2010; Ramenghi et al., 2011;
Volpe, 2015; Bermick et al., 2016; Romantsik et al., 2017; Inder
et al., 2018; Poryo et al., 2018).
Several studies suggest that IVH is unequally distributed
among the different leading causes of very preterm delivery
(DiSalvo, 1998; Chevallier et al., 2017). An estimated 40% of
very preterm births are associated with placental inflammation,
which is often subclinical. This inflammation may be localized
to the maternal placenta or membrane (chorioamnionitis) or
may extend to the fetus, inducing an inflammatory response,
which is evidenced by funisitis (Cornette, 2004; Gantert et al.,
2010; Tita and Andrews, 2010; Thomas and Speer, 2011; Pugni
et al., 2016; Jackson et al., 2017). Chorioamnionitis (CA) is
not only a major risk factor for (very) preterm birth, but it
is also considered a major risk factor for the morbidity and
mortality associated with prematurity (Cornette, 2004; Gantert
et al., 2010; Tita and Andrews, 2010; Thomas and Speer, 2011;
Pugni et al., 2016; Jackson et al., 2017). The pathogenetic role
of CA in the development of complications of prematurity, such
as necrotizing enterocolitis (NEC), bronchopulmonary dysplasia
(BPD), PDA, retinopathy of prematurity (ROP), or cerebral
palsy has been addressed in several systematic reviews (Wu and
Colford, 2000; Hartling et al., 2012; Been et al., 2013; Mitra et al.,
2014; Park et al., 2015; Behbodi et al., 2016; Villamor-Martinez
et al., 2018a). Although intrauterine inflammation is a well-
known risk factor for white matter disease of prematurity (Strunk
et al., 2014), the association with IVH is controversial and has
not been yet systematically reviewed. Moreover, a consideration
with any analysis of CA as a risk factor for preterm morbidity,
is accounting for the role of GA, birth weight (BW) and other
baseline characteristics which differ between CA-exposed and
CA-unexposed infants (Hartling et al., 2012; Mitra et al., 2014;
Behbodi et al., 2016; Villamor-Martinez et al., 2018a). With this
in mind, we aimed to perform a systematic review and meta-
analysis of studies exploring the association between CA and
IVH, as well as the role of potential confounding factors.
METHODS
The methodology followed the same structure as earlier meta-
analyses on CA and ROP (Villamor-Martinez et al., 2018a), and
CA and PDA (Behbodi et al., 2016). We developed a protocol a
priori, which specified the objectives, inclusion criteria, method
for evaluating study quality, included outcomes and covariates,
and statistical methodology.We report the study according to the
guidelines for Preferred Reporting Items for Systematic Reviews
and Meta-Analysis (PRISMA) (Moher et al., 2009).
Sources and Search Strategy
We performed a comprehensive literature search in the
PubMed/MEDLINE and EMBASE databases from their
inception to July 1, 2017. The search strategy involved combining
the following keywords in various ways: “chorioamnionitis,”
“intrauterine infection,” “intrauterine inflammation,” “antenatal
infection,” “antenatal inflammation,” “intraventricular
hemorrhage,” “risk factors,” “outcome,” “cohort,” and “case-
control.” No studies were excluded based on language. In
addition, we used the following strategies to identify additional
studies: review of reference lists of previous systematic reviews
on CA, and of articles included in the present review, and the use
of the “cited by” tool in Web of Science and Google Scholar.
Study Selection
We included studies which evaluated infants who were preterm
(<37 weeks) or low BW (<2,500g), as well as studies which used
stricter inclusion criteria. Studies were included if they reported
primary data on the association between CA-exposure and IVH.
We included studies which reported the rate of IVH in infants
with and without CA, and studies which reported the rate of CA
in infants with and without IVH. The results of the total search
were screened independently by two reviewers (O.M.R, E.V.), in
several rounds: first by title only, second by title and abstract,
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and thirdly by consulting the full text. The reviewers resolved
discrepancies in inclusion through discussion and by consulting
a third reviewer (P.D).
Data Extraction
Using a predetermined worksheet, two researchers (E.V.-M.,
O.M.R.) extracted data from the studies included. Another two
investigators (P.D., E.V.) checked the extracted data for accuracy
and completeness. We resolved discrepancies by discussion
and through checking the primary report. The following data
were extracted from each study: citation information, location
of study, primary objective, criteria for inclusion/exclusion of
infants, definitions used for CA and for IVH, infant baseline
characteristics in the total group and the CA-exposed and CA-
unexposed groups, and reported results on the outcomes of
interest (including raw numbers, summary statistics and adjusted
analyses on CA and IVH where available).
Quality Assessment
We used the Newcastle-Ottawa Scale (NOS) for cohort or case-
control studies to assess the methodological quality of included
studies. Three aspects of a study are evaluated by the NOS:
selection, comparability and exposure/outcome, and these are
scored individually and tallied up to a total of 9 points. Two
researchers (E.V.-M. and E.V.) independently used the NOS
to evaluate the quality of each study, and discrepancies were
discussed and resolved by consensus.
Statistical Analysis
We combined and analyzed studies using COMPREHENSIVE
META-ANALYSIS V 3.0 software (CMA, RRID:SCR_012779,
Biostat Inc., Englewood, NJ, USA). We calculated the odds
ratio (OR) and 95% confidence intervals (CI) for dichotomous
outcomes from the data extracted from the studies.We calculated
the mean difference (MD) and 95% CI for continuous outcomes.
We used the method of Wan et al. (2014) to estimate the mean
and standard deviation, when continuous variables were reported
as median and range/interquartile range in studies. We used
a random-effects model to calculate summary statistics, due to
anticipated heterogeneity. This method accounts for both intra-
study and inter-study variability.
A mixed-effects model was used for subgroup analyses
(Borenstein et al., 2009a). This model is characterized by a
random-effects model that combines studies within subgroups,
and a fixed-effects model that combines subgroups together to
create an overall effect. This model does not assume that study-
to-study variance (tau-squared) is the same in all subgroups.
We assessed statistical heterogeneity using the Cochran’s Q
statistic, which reflects the degree of variance, and the I2-statistic,
which describes the proportion of observed variance that is
due to variance in true effect sizes rather than sampling error
(Borenstein et al., 2009b). Visual inspection of funnel plots
and Egger’s regression test were used to evaluate evidence of
publication bias.
We used univariate random-effects meta-regression (method
of moments) to evaluate covariates which may affect the
effect size (Borenstein et al., 2009c). We defined the following
covariates a priori as potential sources of variability: CA type
(clinical or histological), funisitis, differences in GA and BW
between the infants with and without CA, use of ACS, mode of
delivery, rate of preeclampsia, rate of small for gestational age
(SGA), rate of premature rupture of membranes (PROM), rate
of RDS, rate of PDA, rate of early onset sepsis (EOS), rate of
late onset sepsis (LOS) and mortality. We considered probability
values under 0.05 (0.10 for heterogeneity) as statistically
significant.
RESULTS
Description of Studies
After removing duplicates, we found 1,284 potentially relevant
studies, of which 85 (Morales, 1987; Yoon et al., 1995; Gray
et al., 1997; Alexander et al., 1998; Watterberg et al., 1999; Dexter
et al., 2000; Elimian et al., 2000; Kosuge et al., 2000; Hitti et al.,
2001; Suarez et al., 2001; González-Luis et al., 2002; Ohyama
et al., 2002; Fung et al., 2003; Holcroft et al., 2003; Linder et al.,
2003; Ogunyemi et al., 2003; Vergani et al., 2004; Dempsey
et al., 2005; Lau et al., 2005; Osmanagaoglu et al., 2005; Polam
et al., 2005; Sarkar et al., 2005; Babnik et al., 2006; Kaukola
et al., 2006; Mehta et al., 2006; Richardson et al., 2006; Rocha
et al., 2006; Yanowitz et al., 2006; Kirchner et al., 2007; Baumert
et al., 2008; Mu et al., 2008; Zanardo et al., 2008; Been et al.,
2009; Soraisham et al., 2009, 2013; Suppiej et al., 2009; Austeng
et al., 2010; Botet et al., 2010; Kallankari et al., 2010; Lee et al.,
2010, 2011; Mestan et al., 2010; Alfiero Bordigato et al., 2011;
Barrera-Reyes et al., 2011; Hendson et al., 2011; Lim et al., 2011;
Ryckman et al., 2011; Sato et al., 2011; Wirbelauer et al., 2011;
Ahn et al., 2012; Klebermass-Schrehof et al., 2012; Perrone et al.,
2012; Poralla et al., 2012; Rong et al., 2012; Vaihinger et al.,
2012; van Vliet et al., 2012; Xu et al., 2012; Adén et al., 2013;
Erdemir et al., 2013; Gawade et al., 2013; Logan et al., 2013;
Nasef et al., 2013; Salas et al., 2013; Seliga-Siwecka and Kornacka,
2013; Trevisanuto et al., 2013; Tsiartas et al., 2013; Arayici et al.,
2014; Ecevit et al., 2014; Gagliardi et al., 2014; García-Muñoz
Rodrigo et al., 2014; Kidokoro et al., 2014; Liu et al., 2014; Pappas
et al., 2014; Shankaran et al., 2014; Bry et al., 2015; Dalton
et al., 2015; Kim et al., 2015; Oh et al., 2015, 2018; Smit et al.,
2015; Yamada et al., 2015; Bermick et al., 2016; Lu et al., 2016;
Miyazaki et al., 2016; Rodríguez-Trujillo et al., 2016) met the
inclusion criteria. Figure 1 depicts the PRISMA flow diagram
of the search. The included studies evaluated 46,244 infants,
including 13,432 cases of CA. The characteristics of the included
studies are summarized in Supplementary Table 1. Fifty-eight
studies examined the outcomes of maternal CA and included
IVH as one of the outcomes. Twenty-four studies evaluated risk
factors for developing IVH and included maternal CA as of the
risk factors. Five studies studied the association between CA and
IVH as their primary outcome (De Felice et al., 2001; Sarkar et al.,
2005; Babnik et al., 2006; Mehta et al., 2006; Zanardo et al., 2008).
Fifty-four studies used a histological definition of CA and 24
studies used a clinical definition of CA. Only two studies (Hitti
et al., 2001; Kirchner et al., 2007) examined microbiological CA
and IVH. One study (Nasef et al., 2013) provided data on IVH
and its association with histological and clinical CA separately.
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FIGURE 1 | Flow diagram of search process (Moher et al., 2009).
In four studies (Gray et al., 1997; Fung et al., 2003; Klebermass-
Schrehof et al., 2012; Xu et al., 2012) infants were assigned to the
CA group if they presented histological and/or clinical CA.
Quality Assessment
A summary of the quality assessment of each study using the
NOS is shown in Supplementary Table 2. One study received a
quality score of 5 points, 19 studies achieved a quality score of
six points, 43 studies achieved a quality score of seven points, 11
studies achieved a quality score of eight, and 11 studies achieved
the maximum score of 9 points. Studies were downgraded in
quality for not adjusting the risk of IVH for confounders (k =
62), for not defining IVH clearly (k = 9), for only adjusting the
risk of IVH for one confounding factor (k = 7), for not defining
CA clearly (k= 6), and for losing a substantial portion of infants
to follow-up (k= 4).
Analysis Based on Unadjusted Data
Meta-analysis showed that CA exposure was significantly
associated with all grades IVH (Figure 2A), with grades 2–4
IVH (Figure 2B), with grades 1–2 IVH (Figure 2C), and with
grades 3–4 IVH (Figure 2D). When the type of CA was analyzed
separately, histological CA remained significantly associated with
all grades IVH (Figure 3), with grades 2–4 IVH (Figure 2B),
with grades 1–2 IVH (Figure 2C), and with grades 3–4 IVH
(Figure 4). Clinical CA was significantly associated with all
grades IVH (Figure 5) and with grades 3–4 IVH (Figure 6),
but not with grades 1–2 IVH (Figure 2C). There was only one
study providing data on the association of clinical CA and IVH
grades 2–4 (Figure 2B). We could not find significant evidence
of publication bias through visual inspection of the funnel plot
(Figure 7), or through Egger’s regression test.
Analysis of Covariates
To confirm findings from earlier reports (Behbodi et al., 2016;
Villamor-Martinez et al., 2018a) on the differences in baseline
and clinical characteristics between infants with and without CA,
we carried out further meta-analyses. Infants exposed to CA had
significantly lower GA and BW, as shown in Table 1. Moreover,
infants with CA had significantly higher rates of exposure to ACS,
significantly higher rates of PROM, significantly higher rates of
EOS, significantly higher rates of LOS, and significantly higher
rates of PDA (Table 1). Infants with CA also had significantly
lower rates of cesarean delivery, significantly lower rates of
small for gestational age (SGA) and significantly lower rates of
preeclampsia (Table 1).
We carried out meta-regression analysis to determine the
possible influence of GA and BW on the association between CA
Frontiers in Physiology | www.frontiersin.org 4 September 2018 | Volume 9 | Article 1253
Villamor-Martinez et al. Chorioamnionitis and Intraventricular Hemorrhage
FIGURE 2 | Meta-analyses of the association between chorioamnionitis (CA) and intraventricular hemorrhage (IVH), according to definition of IVH. CI, confidence
interval. (A) CA and all grades IVH; (B) CA and grades 2-4 IVH; (C) CA and grades 1–2 IVH; (D) CA and grades 3–4 IVH.
and IVH. As Table 2 shows, meta-regression did not find that
differences inGA or BWhad a significant effect on the association
between CA and IVH.
To further analyze the effect of GA on the risk of IVH, we
carried out subgroup analyses. We found that in the group of
studies where the CA-group did not differ significantly (p> 0.05)
in GA from the control group, CA was a risk factor for all
grades IVH but not for grades 3–4 IVH (Table 3). We analyzed a
subgroup of studies where the CA-group had aMD inGA of≤0.5
weeks, and we found that CA was a risk factor for all grades IVH
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FIGURE 3 | Meta-analysis of the association between histological chorioamnionitis (CA) and all grades intraventricular hemorrhage (IVH). CI, confidence interval.
and for grades 3–4 IVH (Table 3). We also found that in studies
where the CA-group had aMD in GA of less than 1 week, CA was
a risk factor for all grades IVH and for grades 3–4 IVH (Table 3).
To evaluate the role of other prespecified covariates in the
association between CA and IVH, we performed additional
meta-regression analyses. Meta-regression could not find
a significant difference in IVH risk between infants with
clinical and infants with histological CA (Table 4). Meta-
regression did find a significant association between the
CA-associated risk of grades 3–4 IVHand the risk of preeclampsia
(Supplementary Figure 1),mortality (Supplementary Figure 2),
risk of LOS (Supplementary Figure 3) and risk of PDA
(Supplementary Figure 4) Other meta-regressions could not
find a significant association between the CA-associated risk of
IVH and other covariates (Table 4).
Analysis of Funisitis
To evaluate the role of funisitis (i.e., fetal inflammatory response)
in the development of IVH, we carried out further meta-analyses.
Thirteen studies reported on IVH (Ohyama et al., 2002; Lau et al.,
2005; Babnik et al., 2006; Richardson et al., 2006; Rocha et al.,
2006; Been et al., 2009; Mestan et al., 2010; Logan et al., 2013;
Trevisanuto et al., 2013; Tsiartas et al., 2013; Liu et al., 2014; Kim
et al., 2015; Smit et al., 2015) in infants with histological CA with
or without funisitis. As shown in Figure 8, meta-analysis could
not show a significant difference in IVH risk between infants with
funisitis and infants with CA without funisitis (OR all grades
IVH: 1.22, 95% CI 0.89 to 1.67; grades 3-4 IVH: 1.17, 95% CI
0.74 to 1.85). Using meta-regression, we also found no significant
difference in IVH risk between infants with funisitis, and infants
with CA without funisitis (Table 4).
Analysis Based on Adjusted Data
Thirteen studies adjusted the association between CA and
the risk of IVH for confounding factors. As shown in
Supplementary Tables 3, 4, studies adjusted for different
covariates. Meta-analysis pooling this adjusted data found that
CA was significantly associated with a higher risk of all grades
IVH (OR 1.25, 95% CI 1.02–1.53, Supplementary Table 3).
This association became non-significant when only
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FIGURE 4 | Meta-analysis of the association between histological chorioamnionitis (CA) and grades 3–4 intraventricular hemorrhage (IVH). CI, confidence interval.
analyzing studies which used a histological definition of
CA (Supplementary Table 3). Meta-analysis of adjusted data
also found a significant association between CA and grades 3–4
IVH (OR 1.22, 95% CI 1.04–1.43, Supplementary Table 4). This
association became non-significant when grouping studies by
clinical or histological CA definition (Supplementary Table 4).
DISCUSSION
The current systematic review and meta-analysis demonstrates
that both clinical and histological CA are associated with an
increased risk for developing IVH in very preterm infants. In
contrast, the presence of funisitis did not increase IVH risk
when compared to CA in the absence of funisitis. We found
through additional meta-analyses that CA-exposed infants had
significantly lower GA and BW than infants not exposed to
CA. However, meta-regression and subgroup analysis could not
demonstrate an association between the lower GA and BW and
the risk of IVH in the CA-exposed infants. This suggests that the
effects of CA on IVH risk might be at least partially independent
on the role of CA as an etiological factor for very preterm birth.
The association between CA and increased risk of IVH is
biologically and clinically plausible. IVH generally occurs within
the three first days of life and affects the infants with higher
hemodynamic and respiratory instability, frequently associated
with extreme prematurity and/or severe perinatal infections
(Mohamed and Aly, 2010; Inder et al., 2018). Therefore, the
clinical circumstances around birth and during the first days of
life are critical for the development of IVH. Our study confirms
previous reports showing that these clinical circumstances are
different in CA-exposed and CA–unexposed very preterm infants
(Hartling et al., 2012; Behbodi et al., 2016; Villamor-Martinez
et al., 2018a). Thus, CA-exposed infants were born 1.2 weeks
earlier, they were 55g lighter at birth, and they were more
frequently exposed to ACS, PROM, vaginal delivery, early and
late onset sepsis, and PDA. As mentioned in the introduction,
some of these factors may have affected IVH risk.
The degree of prematurity is the most important predisposing
factor for the occurrence of IVH (Ballabh, 2010; Volpe, 2015;
Inder et al., 2018), as well as for other complications of
prematurity such as BPD, ROP, NEC, or PDA (Hartling et al.,
2012; Been et al., 2013; Mitra et al., 2014; Behbodi et al., 2016;
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FIGURE 5 | Meta-analysis of the association between clinical chorioamnionitis (CA) and all grades intraventricular hemorrhage (IVH). CI, confidence interval.
FIGURE 6 | Meta-analysis of the association between clinical chorioamnionitis (CA) and grades 3–4 intraventricular hemorrhage (IVH). CI, confidence interval.
Villamor-Martinez et al., 2018a). Nevertheless, very preterm birth
is always a pathological event and very preterm infants have a
morbidity andmortality risk associated with whichever condition
led to their early delivery (McElrath et al., 2008; Wilcox et al.,
2011; Gagliardi et al., 2013; Barros et al., 2015). Therefore, CA
may affect infant morbidity through inducing very preterm birth
or through the deleterious effects of infection/inflammation.
Interestingly, previous meta-analyses showed an association
between the lower gestational age of the CA-exposed group
and the CA-associated risk of BPD (Hartling et al., 2012), PDA
(Behbodi et al., 2016), and ROP (Mitra et al., 2014; Villamor-
Martinez et al., 2018a). In contrast, our meta-regression could
not show that the difference in GA between CA-exposed and
CA-unexposed infants significantly correlated with IVH risk.
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FIGURE 7 | Funnel plots assessing publication bias for the association between chorioamnionitis (CA) and intraventricular hemorrhage (IVH).
Moreover, we performed subgroup analyses in which we only
included the studies showing small or no differences in GA
between the CA-exposed and the control group and we observed
that the significant IVH risk was maintained in this subgroup of
studies. In contrast, this was not the case when the same subgroup
analysis was performed for PDA (Behbodi et al., 2016) or ROP
(Mitra et al., 2014; Villamor-Martinez et al., 2018a). Altogether
this suggests that CAmay increase complications such as PDA or
ROP through GA-dependent mechanisms, whereas the effect on
IVH may be mediated by GA-independent mechanisms.
Besides GA, several other factors potentially confound the
association between CA and IVH. A number of studies
provided data adjusted for confounding factors, but confounders
accounted for in each model differed across studies. We
performed separate analyses aggregating adjusted association
measures. This reduced or made non-significant the association
between CA and IVH (Supplementary Tables 3, 4). Earlier
meta-analyses on the association between CA and cerebral
palsy (Wu and Colford, 2000), BPD (Hartling et al., 2012),
ROP (Villamor-Martinez et al., 2018a) also showed that the
positive association found when unadjusted data were pooled,
was reduced or became non-significant when only adjusted data
were pooled. Moreover, in our previous meta-analysis on CA and
PDA (Behbodi et al., 2016) we found that CA was risk factor
for PDA when unadjusted data were pooled, and that CA was a
protective factor for PDA when adjusted data were pooled.
Adjustment for potential confounders, particularly for GA
and/or BW, is a common strategy used in observational studies
analyzing predictors of outcomes of prematurity (Gagliardi et al.,
2013). Quality assessment tools such as the NOS even downgrade
studies for not adjusting for confounding factors. However,
adjustment for GA and BW is controversial and can arguably
lead to biased conclusions (Wilcox et al., 2011; Gagliardi et al.,
2013). Preterm infants are at risk of adverse outcomes both due to
their immaturity and due to the pathological conditions that led
to their preterm birth (McElrath et al., 2008; Basso and Wilcox,
2010; Wilcox et al., 2011; Gagliardi et al., 2013). Very low GA
is therefore both a risk factor for adverse outcomes, as well as
a mediator in the causal pathway that links preterm birth to
adverse outcomes (Wilcox et al., 2011; Gagliardi et al., 2013). The
problem with adjusting for intermediate variables, such as GA, is
that it may introduce bias unless each confounder is accounted
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TABLE 1 | Meta-analysis of the association between chorioamnionitis and covariates.
Meta-analysis Chorioamnionitis k Effect size 95% CI Z p Heterogeneity
Q p I2
Gestational age (weeks) Clinical 11 MD −0.73 −1.16 to −0.30 −3.35 0.001 140 <0.001 92.9
Histological 42 MD −1.27 −1.49 to −1.05 −11.42 <0.001 495 <0.001 91.7
Any type 56 MD −1.20 −1.40 to −1.00 −11.66 <0.001 839 <0.001 93.4
Birth weight (g) Clinical 11 MD −29.14 −77.66 to 19.39 −1.18 0.239 107 <0.001 90.6
Histological 41 MD −70.21 −96.71 to −43.72 −5.19 <0.001 362 <0.001 89.0
Any type 55 MD −55.00 −74.89 to −35.12 −5.42 <0.001 474 <0.001 88.6
Antenatal corticosteroids Clinical 5 OR 1.10 0.76 to 1.60 0.52 0.605 55 <0.001 92.8
Histological 31 OR 1.20 1.01 to 1.42 2.03 0.043 95 <0.001 68.3
Any type 38 OR 1.19 1.02 to 1.38 2.28 0.023 155 <0.001 76.1
Cesarean section Clinical 8 OR 0.53 0.30 to 0.93 −2.23 0.026 316 <0.001 97.8
Histological 28 OR 0.33 0.25 to 0.45 −7.32 <0.001 177 <0.001 84.8
Any type 36 OR 0.37 0.29 to 0.47 −8.06 <0.001 495 <0.001 92.9
SGA Histological 15 OR 0.33 0.23 to 0.49 −5.53 <0.001 79 <0.001 82.3
Any type 16 OR 0.34 0.23 to 0.50 −5.64 <0.001 80 <0.001 81.2
Preeclampsia Clinical 3 OR 0.16 0.09 to 0.29 −5.98 <0.001 2 0.369 <0.001
Histological 23 OR 0.15 0.11 to 0.20 −13.09 <0.001 65 <0.001 66.2
Any type 27 OR 0.15 0.12 to 0.20 −15.25 <0.001 69 <0.001 62.2
PROM Clinical 3 OR 5.02 2.71 to 9.31 5.12 <0.001 2 <0.001 18
Histological 27 OR 3.14 2.54 to 3.87 10.63 <0.001 149 <0.001 82.6
Any type 30 OR 3.29 2.70 to 4.02 11.76 <0.001 155 <0.001 81.3
Male sex Clinical 8 OR 1.10 0.80 to 1.53 0.58 0.560 80 <0.001 91.2
Histological 35 OR 0.99 0.89 to 1.11 −0.15 0.881 91 <0.001 62.8
Any type 46 OR 1.00 0.90 to 1.12 0.07 0.941 193 <0.001 76.7
Maternal diabetes Any type 9 OR 0.81 0.65 to 1.01 −1.92 0.055 5 0.725 0.0
EOS Clinical 7 OR 4.41 3.58 to 5.42 14.08 <0.001 9 0.197 30.3
Histological 18 OR 2.62 1.88 to 3.65 5.68 <0.001 48 <0.001 64.9
Any type 25 OR 3.81 3.20 to 4.54 14.96 <0.001 87 <0.001 72.4
LOS Clinical 5 OR 1.41 1.10 to 1.81 2.68 0.007 17 0.002 76.8
Histological 30 OR 1.53 1.27 to 1.84 4.45 <0.001 134 <0.001 78.3
Any type 37 OR 1.55 1.34 to 1.80 5.82 <0.001 174 <0.001 79.3
PDA Clinical 4 OR 1.30 1.04 to 1.64 2.27 0.023 7 0.062 59.0
Histological 26 OR 1.41 1.15 to 1.72 3.35 0.001 144 <0.001 82.6
Any type 31 OR 1.60 1.35 to 1.80 6.00 <0.001 195 <0.001 84.6
RDS Clinical 3 OR 2.01 0.48 to 8.41 0.95 0.341 11 0.004 82.0
Histological 15 OR 1.09 0.81 to 1.45 0.55 0.582 89 <0.001 84.3
Any type 21 OR 1.00 0.78 to 1.29 0.01 0.990 149 <0.001 86.6
CI, confidence interval; MD, mean difference; OR, odds ratio; SGA, small for gestational age; PROM, premature rupture of membranes; EOS, early-onset sepsis; LOS, late-onset sepsis;
PDA, patent ductus arteriosus; RDS, respiratory distress syndrome.
for in the model (Hernández-Díaz et al., 2006; Basso andWilcox,
2010; Wilcox et al., 2011; Gagliardi et al., 2013). As discussed by
Gagliardi et al., “the difficulty of achieving—at least at the current
level of knowledge of etiology of preterm birth—full control of
all mediator–outcome confounders limits the possibility of causal
interpretation of the associations found but not their descriptive
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TABLE 2 | Random effects meta-regression of IVH risk in the chorioamnionitis group, and mean difference in gestational age and birth weight.
IVH grade Meta-regression k CC 95% CI Z p R2
All grades IVH Mean difference gestational age (per week) 35 −0.02 −0.19 to 0.16 −0.17 0.863 0.00
Mean difference birth weight (per 100 g) 35 0.00 −0.001 to 0.001 0.07 0.942 0.00
Grades 1–2 IVH Mean difference gestational age (per week) 20 0.05 −0.15 to 0.25 0.51 0.613 0.00
Mean difference birth weight (per 100 g) 20 0.13 −0.07 to 0.33 1.27 0.203 0.54
Grades 3–4 IVH Mean difference gestational age (per week) 37 −0.19 −0.43 to 0.04 −1.62 0.105 0.29
Mean difference birth weight (per 100 g) 37 −0.10 −0.30 to 0.10 −1.01 0.312 0.00
IVH, intraventricular hemorrhage; k, number of included studies; CC, coefficient; CI, confidence interval.
TABLE 3 | Subgroup meta-analyses based on difference in gestational age (GA).
Subgroup of studies IVH definition k OR 95% CI p
Studies where CA-group did not differ significantly in GA from control (p > 0.05) All grades IVH 15 1.59 1.20 to 2.10 0.001
Grades 3–4 IVH 14 1.54 0.99 to 2.39 0.055
Studies where CA-group did differ significantly in GA from control (p < 0.05) All grades IVH 20 1.71 1.46 to 2.01 < 0.001
Grades 3–4 IVH 23 1.90 1.56 to 2.33 0.000
Studies where CA-group had a MD in GA of ≤0.5 weeks compared to control All grades IVH 11 1.66 1.25 to 2.22 < 0.001
Grades 3–4 IVH 13 1.36 1.03 to 1.80 0.028
Studies where CA-group had a MD in GA of >0.5 weeks compared to control All grades IVH 24 1.68 1.43 to 1.98 < 0.001
Grades 3–4 IVH 23 1.99 1.64 to 2.41 < 0.001
Studies where CA-group had a MD in GA of <1 weeks compared to control All grades IVH 16 1.72 1.37 to 2.15 < 0.001
Grades 3–4 IVH 18 1.52 1.21 to 1.92 < 0.001
Studies where CA-group had a MD in GA of ≥1 weeks compared to control All grades IVH 19 1.65 1.37 to 1.97 < 0.001
Grades 3–4 IVH 18 2.00 1.60 to 2.50 < 0.001
CA, chorioamnionitis; GA, gestational age; IVH, intraventricular hemorrhage; k, number of studies included; CI, confidence interval; MD, mean difference.
value” (121, p. 798). In this sense, by providing analysis of both
the unadjusted and adjusted data, our study may be a valuable
contribution to the understanding of CA as etiopathogenic factor
of both prematurity and IVH.
Our data suggest that CA-exposed infants are not only
younger but also more clinically unstable than the non-exposed
infants. This is reflected in the higher mortality and the higher
rate of sepsis and PDA in CA-exposed infants (Table 1). Of note,
meta-regression showed a correlation between the effect size of
the association between CA and grade 3-4 IVH and the effect
sizes of the association between CA and PDA. As mentioned
elsewhere, the presence of a hemodynamically relevant PDA has
been correlated with the occurrence of IVH and the proposed
mechanism is the disturbance of cerebral blood flow (Ballabh,
2010, 2014; Inder et al., 2018; Poryo et al., 2018). Our data
support this association between IVH and PDA in CA-exposed
infants.
The biological plausibility of the association between CA
and IVH is supported by the direct and indirect effects of
inflammatory mediators. Hemodynamic disturbances in preterm
infants with CA have been correlated with elevated cord blood
concentrations of proinflammatory cytokines such as IL-6,
IL-1beta and TNF-alpha (Yanowitz et al., 2002). Cytokines
can act directly on the vascular smooth muscle, producing
vascular relaxation and hypotension or indirectly by increasing
the production of endothelium-derived vasoactive mediators
(Yanowitz et al., 2002). In addition, cytokines can eventually
promote a neuro-inflammatory cascade in the fetal brain
penetrating across the blood brain barrier or activating specific
receptors such as CD14 and TLR4 which are constitutively
expressed in the circumventricular organs, choroid plexus and
leptomeninges (Rivest, 2003;McAdams and Juul, 2012). Inflamed
glial or endothelial cells, challenged by external stimuli, enhance
the release/expression of various chemoattractants and adhesion
molecules which may promote the platelet and neutrophil
activation and adhesion determining possible endothelial cell
damage and changes in blood rheology and flow (Stanimirovic
and Satoh, 2000; Molina-Holgado and Molina-Holgado, 2010).
These changes, occurring inside the fragile germinal matrix
capillaries or within the vascular connection between germinal
matrix and the subependymal venous network, may increase the
likelihood of IVH in preterm infants with CA.
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TABLE 4 | Random effects meta-regression of IVH risk in the chorioamnionitis group, and predefined covariates.
IVH grade Meta-regression k CC 95% CI Z P R2
All grades IVH Chorioamnionitis type (histological/clinical) 49 −0.08 −0.45 to 0.29 −0.42 0.673 0.00
Funisitis (CA+F+ vs. CA+F–) 9 −0.12 −0.62 to 0.38 −0.49 0.627 0.00
ACS (log OR) 25 0.01 −0.46 to 0.49 0.05 0.964 0.00
Cesarean section (log OR) 22 −0.07 −0.47 to 0.32 −0.36 0.717 0.00
Maternal age (MD) 17 −0.08 −0.24 to 0.07 −1.09 0.276 0.00
SGA (log OR) 11 0.39 −0.09 to 0.88 1.59 0.111 0.54
PROM (log OR) 20 −0.40 −1.06 to 0.26 −1.19 0.233 0.08
Preeclampsia (log OR) 16 0.03 −0.40 to 0.45 0.13 0.897 0.00
Mortality (log OR) 26 0.18 −0.15 to 0.50 1.07 0.285 0.07
Early onset sepsis (log OR) 14 0.13 −0.47 to 0.73 0.42 0.672 0.00
Late onset sepsis (log OR) 24 −0.04 −0.39 to 0.32 −0.19 0.846 0.00
PDA (log OR) 22 0.13 −0.21 to 0.48 0.75 0.453 0.00
RDS (log OR) 21 0.02 −0.22 to 0.27 0.22 0.827 0.00
Grades 3–4 IVH Chorioamnionitis type (histological/clinical) 46 −0.07 −0.44 to 0.30 −0.37 0.708 0.00
Funisitis (CA+F+ vs. CA+F–) 8 0.07 −0.29 to 0.44 0.40 0.691 0.00
ACS (log OR) 28 −0.11 −0.60 to 0.38 0.42 0.672 0.00
Cesarean section (log OR) 27 0.08 −0.09 to 0.26 0.92 0.358 0.06
Maternal age (MD) 18 −0.01 −0.25 to 0.22 −0.11 0.911 0.00
SGA (log OR) 12 0.24 −0.19 to 0.67 1.08 0.280 0.22
PROM (log OR) 22 −0.09 −0.35 to 0.17 −0.65 0.515 0.00
Preeclampsia (log OR) 18 0.41 0.20 to 0.63 3.74 0.0004 1.00
Mortality (log OR) 30 0.42 0.17 to 0.67 3.33 0.001 0.58
Early onset sepsis (log OR) 20 0.11 −0.32 to 0.54 0.51 0.613 0.00
Late onset sepsis (log OR) 26 0.35 0.01 to 0.70 1.99 0.047 0.22
PDA (log OR) 21 0.40 0.04 to 0.76 2.18 0.029 0.48
RDS (log OR) 27 −0.06 −0.34 to 0.21 −0.49 0.627 0.14
k, number of studies included; CA, chorioamnionitis; F, funisitis; CC, coefficient; CI, confidence interval; MD, mean difference; OR, odds ratio; ACS, antenatal corticosteroids; SGA, small
for gestational age; PROM, premature rupture of membranes; PDA, patent ductus arteriosus; RDS, respiratory distress syndrome.
We have discussed the role of funisitis in earlier meta-
analyses on CA and ROP (Villamor-Martinez et al., 2018a) and
CA and PDA (Behbodi et al., 2016). It is worth noting that
not all intraamniotic infections will induce an inflammatory
response in the fetus (Revello et al., 2015). Funisitis is generally
considered the histologic counterpart to fetal inflammatory
response syndrome (Gantert et al., 2010; Revello et al., 2015). We
found that exposure to funisitis did not significantly increase the
risk of IVH, when compared to exposure to CA without funisitis.
This is an argument against role of the fetal inflammatory
response in the etiopathogenesis of IVH. We have previously
reported that funisitis is not an additional risk factor for
developing PDA (Behbodi et al., 2016) but the presence of
funisitis significantly increased the risk of developing severe ROP
(Villamor-Martinez et al., 2018a).
Our meta-analysis has several limitations that should be
considered. Firstly, there was substantial heterogeneity in how
CA was defined in studies. The definitions of clinical CA in
particular varied substantially, and recent recommendations
propose restricting the term CA to pathologic diagnosis (Higgins
et al., 2016). Secondly, only 5 out of 85 included studies
studied the association between CA and IVH as their main
objective. However, this could also have reduced the effect
of publication bias. Thirdly, only 13 out of the 85 included
studies provided adjusted data, and they used different models
and adjusted for different confounders. Finally, in this study
and earlier studies on ROP (Villamor-Martinez et al., 2018a)
and PDA (Behbodi et al., 2016), we had a much more limited
number of studies to draw from for analyzing funisitis than
when analyzing CA. The strengths of our study include: the use
of a comprehensive search, duplication of screening, inclusion
and data extraction to reduce bias, a large number of included
studies, and an extensive analysis of confounding factors, through
meta-analysis, meta-regression and the inclusion of adjusted
data.
A significant limitation in any meta-analysis on IVH is
the potential for heterogeneity in defining the condition. The
grading system most commonly used for neonatal IVH was first
reported by Papile et al. and later modified by Volpe and is
based on the presence and amount of blood in the germinal
matrix, lateral ventricles, and periventricular white matter
(Volpe, 2015). Grade 1 represents germinal matrix hemorrhage
only with no or minimal IVH (<10% of ventricular area on
parasagittal view). When IVH occupies 10–50% of ventricular
area on parasagittal view, it is defined as grade 2 (Volpe,
2015). Grade 3 is IVH with blood occupying more than 50%
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FIGURE 8 | Meta-analysis of the association between funisitis and intraventricular hemorrhage (IVH). Fun, funisitis; CI, confidence interval.
of the ventricular area on parasagittal view. Grade 4 represents
severe IVH with associated periventricular echodensity (Volpe,
2015). Although grade 4 IVH is a periventricular hemorrhagic
infarction rather than an extension of IVH per se, the 1–4
grading system remains pervasive in the literature and clinical
setting despite debate regarding appropriate nomenclature
(Leviton et al., 2007). In addition grade 3 and 4 IVHs are
frequently grouped together as severe or high grade IVH
(Leviton et al., 2007). Nevertheless, our meta-analysis shows
a significant increased risk of both severe and less severe
(grade 1–2) IVH in CA-exposed infants. Therefore, potential
differences in IVH classification may not have affected the
results.
CONCLUSION
IVH is a multifactorial complication that is more common
in more preterm and more clinically unstable infants. We
established for the first time through meta-analysis that CA is a
risk factor for IVH. We also confirmed earlier findings that CA
is a risk factor for being born more preterm and presenting more
clinical instability. However, in contrast to other complications
of prematurity, such as PDA, ROP, or BPD (Hartling et al., 2012;
Mitra et al., 2014; Behbodi et al., 2016; Villamor-Martinez et al.,
2018a), the effect of CA on IVH appears to be independent of CA
as a causative factor for very preterm birth.
DATA AVAILABILITY STATEMENT
The datasets generated and analyzed for this study can be found
in the Harvard Dataverse (Harvard Dataverse, 2018): https://
dataverse.harvard.edu/dataset.xhtml?persistentId=doi%3A10.
7910%2FDVN%2FJ9RHUF.
A preprint version of this manuscript is made available
to the scientific community on the preprint server bioRxiv
(Villamor-Martinez et al., 2018b): https://www.biorxiv.org/
content/early/2018/05/30/334375.
AUTHOR CONTRIBUTIONS
EV-M carried out data collection, carried out statistical analyses,
assessed methodological quality, contributed to interpretation of
results, drafted the initial manuscript, and reviewed and revised
the manuscript. MF contributed to the design of the study, the
statistical analysis and interpretation of results and reviewed
and revised the manuscript. OM selected studies for inclusion,
carried out data collection and carried out statistical analyses.
SP contributed to interpretation of results and reviewed and
revised the manuscript. GC contributed to interpretation of
results and reviewed and revised the manuscript. PD carried out
and supervised data collection and contributed to interpretation
of results. FM contributed to interpretation of results and
reviewed and revised the manuscript. EV conceptualized and
Frontiers in Physiology | www.frontiersin.org 13 September 2018 | Volume 9 | Article 1253
Villamor-Martinez et al. Chorioamnionitis and Intraventricular Hemorrhage
designed the study, carried out the search and selected studies
for inclusion, supervised data collection, contributed to statistical
analyses and interpretation of results, and reviewed and revised
the manuscript. All authors approved the final manuscript as
submitted.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fphys.
2018.01253/full#supplementary-material
REFERENCES
Adén, U., Lin, A., Carlo, W., Leviton, A., Murray, J. C., Hallman, M., et al. (2013).
Candidate gene analysis: severe intraventricular hemorrhage in inborn preterm
neonates. J. Pediatr. 163:1503-6. e1. doi: 10.1016/j.jpeds.2013.06.025
Ahn, H. M., Park, E. A., Cho, S. J., Kim, Y.-J., and Park, H.-S. (2012). The
association of histological chorioamnionitis and antenatal steroids on neonatal
outcome in preterm infants born at less than thirty-four weeks’ gestation.
Neonatology 102, 259–264. doi: 10.1159/000339577
Alexander, J. M., Gilstrap, L. C., Cox, S. M., McIntire, D. M., and Leveno, K. J.
(1998). Clinical chorioamnionitis and the prognosis for very low birth weight
infants. Obstet. Gynecol. 91(5 Part 1), 725–729.
Alfiero Bordigato, M., Piva, D., Di Gangi, I. M., Giordano, G., Chiandetti, L.,
and Filippone, M. (2011). Asymmetric dimethylarginine in ELBW
newborns exposed to chorioamnionitis. Early Hum. Dev. 87, 143–145.
doi: 10.1016/j.earlhumdev.2010.11.004
Arayici, S., Kadioglu Simsek, G., Oncel, M. Y., Eras, Z., Canpolat, F. E., Oguz, S.
S., et al. (2014). The effect of histological chorioamnionitis on the short-term
outcome of preterm infants≤ 32 weeks: a single-center study. J. Matern. Fetal
Neonatal Med. 27, 1129–1133. doi: 10.3109/14767058.2013.850668
Austeng, D., Blennow, M., Ewald, U., Fellman, V., Fritz, T., Hellstrom-Westas, L.,
et al. (2010). Incidence of and risk factors for neonatal morbidity after active
perinatal care: extremely preterm infants study in Sweden (EXPRESS). Acta
Paediatr. 99, 978–992. doi: 10.1111/j.1651-2227.2010.01846.x
Babnik, J., Stucin-Gantar, I., Kornhauser-Cerar, L., Sinkovec, J., Wraber, B.,
and Derganc, M. (2006). Intrauterine inflammation and the onset of peri-
intraventricular hemorrhage in premature infants. Neonatology 90, 113–121.
doi: 10.1159/000092070
Ballabh, P. (2010). Intraventricular hemorrhage in premature infants: mechanism
of disease. Pediatr. Res. 67, 1–8. doi: 10.1203/PDR.0b013e3181c1b176
Ballabh, P. (2014). Pathogenesis and prevention of intraventricular hemorrhage.
Clin. Perinatol. 41, 47–67. doi: 10.1016/j.clp.2013.09.007
Barrera-Reyes, R., Ruiz-Macias, H., and Segura-Cervantes, E. (2011).
[Neurodevelopment at one year of age (corrected) in preterm newborns
with history of maternal chorioamnionitis]. Ginecol. Obstet. Mex. 79,
31–37.
Barros, F. C., Papageorghiou, A. T., Victora, C. G., Noble, J. A., Pang, R.,
Iams, J., et al. (2015). The distribution of clinical phenotypes of preterm
birth syndrome: implications for prevention. JAMA Pediatr. 169, 220–229.
doi: 10.1001/jamapediatrics.2014.3040
Basso, O., and Wilcox, A. (2010). Mortality risk among preterm babies:
immaturity vs. underlying pathology. Epidemiology 21, 521–527.
doi: 10.1097/EDE.0b013e3181debe5e
Baumert, M., Brozek, G., Paprotny, M., Walencka, Z., Sodowska, H., Cnota, W.,
et al. (2008). Epidemiology of peri/intraventricular haemorrhage in newborns
at term. J. Physiol. Pharmacol. 59(Suppl. 4), 67–75.
Been, J. V., Lievense, S., Zimmermann, L. J., Kramer, B. W., and Wolfs, T. G.
(2013). Chorioamnionitis as a risk factor for necrotizing enterocolitis:
a systematic review and meta-analysis. J. Pediatr. 162, 236-42 e2.
doi: 10.1016/j.jpeds.2012.07.012
Been, J. V., Rours, I. G., Kornelisse, R. F., Lima Passos, V., Kramer, B. W.,
Schneider, T. A., et al. (2009). Histologic chorioamnionitis, fetal involvement,
and antenatal steroids: effects on neonatal outcome in preterm infants. Am.
Obstet. Gynecol. 201, 587. e1-e8. doi: 10.1016/j.ajog.2009.06.025
Behbodi, E., Villamor-Martínez, E., Degraeuwe, P. L., and Villamor, E. (2016).
Chorioamnionitis appears not to be a risk factor for patent ductus arteriosus
in preterm infants: a systematic review and meta-analysis. Sci. Rep. 6:37967.
doi: 10.1038/srep37967
Bermick, J., Dechert, R. E., and Sarkar, S. (2016). Does hyperglycemia
in hypernatremic preterm infants increase the risk of intraventricular
hemorrhage? J. Perinatol. 36, 729–732. doi: 10.1038/jp.2016.86
Borenstein, M., Hedges, L. V., Higgins, J., and Rothstein, H. R. (2009a). Subgroup
Analyses. Introduction to Meta-Analysis. Chichester, UK: John Wiley & Sons.
Borenstein, M., Hedges, L. V., Higgins, J., and Rothstein, H. R. (2009b).
Identifying and Quantifying Heterogeneity. Introduction to Meta-Analysis.
Chichester, UK: John Wiley & Sons.
Borenstein, M., Hedges, L. V., Higgins, J., and Rothstein, H. R. (2009c). Meta-
Regression. Introduction to Meta-Analysis. Chichester, UK: John Wiley & Sons.
Botet, F., Figueras, J., Carbonell-Estrany, X., Arca, G., and Group, C. S. (2010).
Effect of maternal clinical chorioamnionitis on neonatal morbidity in very-
low birthweight infants: a case-control study. J. Perinat. Med. 38, 269–273.
doi: 10.1515/jpm.2010.029
Bry, K. J., Jacobsson, B., Nilsson, S., and Bry, K. (2015). Gastric fluid cytokines
are associated with chorioamnionitis and white blood cell counts in preterm
infants. Acta Paediatr. 104, 575–580. doi: 10.1111/apa.12947
Chevallier, M., Debillon, T., Pierrat, V., Delorme, P., Kayem, G., Durox, M., et al.
(2017). Leading causes of preterm delivery as risk factors for intraventricular
hemorrhage in very preterm infants: results of the EPIPAGE 2 cohort study.
Am. J. Obstet. Gynecol. 216, 518. e1-. e12. doi: 10.1016/j.ajog.2017.01.002
Cornette, L. (2004). Fetal and neonatal inflammatory response
and adverse outcome. Semin. Fetal Neonatal Med. 9, 459–470.
doi: 10.1016/j.siny.2004.08.004
Dalton, J., Dechert, R. E., and Sarkar, S. (2015). Assessment of association
between rapid fluctuations in serum sodium and intraventricular
hemorrhage in hypernatremic preterm infants. Am. J. Perinatol. 32, 795–802.
doi: 10.1055/s-0034-1396691
De Felice, C., Toti, P., Laurini, R. N., Stumpo, M., Picciolini, E., Todros, T., et al.
(2001). Early neonatal brain injury in histologic chorioamnionitis. J. Pediatr.
138, 101–104. doi: 10.1067/mpd.2001.109605
Dempsey, E., Chen, M.-F., Kokottis, T., Vallerand, D., and Usher, R.
(2005). Outcome of neonates less than 30 weeks gestation with histologic
chorioamnionitis. Am. J. Perinatol. 22, 155–159. doi: 10.1055/s-2005-865020
Dexter, S. C., Pinar, H., Malee, M. P., Hogan, J., Carpenter, M. W.,
and Vohr, B. R. (2000). Outcome of very low birth weight infants
with histopathologic chorioamnionitis. Obstet. Gynecol. 96, 172–177.
doi: 10.1016/S0029-7844(00)00886-3
DiSalvo, D. (1998). The correlation between placental pathology and
intraventricular hemorrhage in the preterm infant. The developmental
epidemiology network investigators. Pediatr. Res. 43, 15–19.
Ecevit, A., Anuk-Ince, D., Yapak,çi, E., Kupana-Ayva, S., Kurt, A., Yanik, F. F., et al.
(2014). Association of respiratory distress syndrome and perinatal hypoxia with
histologic chorioamnionitis in preterm infants. Turk. J. Pediatr. 56, 56–61.
Elimian, A., Verma, U., Beneck, D., Cipriano, R., Visintainer, P., and
Tejani, N. (2000). Histologic chorioamnionitis, antenatal steroids, and perinatal
outcomes. Obstet. Gynecol. 96, 333–336. doi: 10.1016/S0029-7844(00)00928-5
Erdemir, G., Kultursay, N., Calkavur, S., Zekioglu, O., Koroglu, O. A.,
Cakmak, B., et al. (2013). Histological chorioamnionitis: effects on
premature delivery and neonatal prognosis. Pediatr. Neonatol. 54, 267–274.
doi: 10.1016/j.pedneo.2013.03.012
Fung, G., Bawden, K., Chow, P., and Yu, V. (2003). Long-term outcome of
extremely preterm infants following chorioamnionitis絨毛膜羊膜炎對極早
早產兒的長影響. HK J Paediatr (new series) 8, 87–92.
Gagliardi, L., Rusconi, F., Bell,ù, R., Zanini, R., and Network, I. N.
(2014). Association of maternal hypertension and chorioamnionitis
with preterm outcomes. Pediatrics 134, e154–e61. doi: 10.1542/peds.
2013-3898
Frontiers in Physiology | www.frontiersin.org 14 September 2018 | Volume 9 | Article 1253
Villamor-Martinez et al. Chorioamnionitis and Intraventricular Hemorrhage
Gagliardi, L., Rusconi, F., Da Fr,è, M., Mello, G., Carnielli, V., Di Lallo, D., et al.
(2013). Pregnancy disorders leading to very preterm birth influence neonatal
outcomes: results of the population-based ACTION cohort study. Pediatr. Res.
73, 794–801. doi: 10.1038/pr.2013.52
Gantert, M., Been, J. V., Gavilanes, A. W., Garnier, Y., Zimmermann,
L. J., and Kramer, B. W. (2010). Chorioamnionitis: a multiorgan
disease of the fetus? J Perinatol 30(Suppl.), S21–S30. doi: 10.1038/jp.
2010.96
García-Muñoz Rodrigo, F., Galan Henriquez, G., Figueras Aloy, J., Garcia-
Alix Perez, A., and Network, S. (2014). Outcomes of very-low-birth-weight
infants exposed to maternal clinical chorioamnionitis: a multicentre study.
Neonatology 106, 229–234. doi: 10.1159/000363127
Gawade, P. L., Whitcomb, B. W., Chasan-Taber, L., Pekow, P. S.,
Ronnenberg, A. G., Shah, B., et al. (2013). Second stage of labor
and intraventricular hemorrhage in early preterm infants in the
vertex presentation. J. Matern. Fetal Neonatal Med. 26, 1292–1298.
doi: 10.3109/14767058.2013.783804
González-Luis, G., García, I. J., Rodríguez-Miguélez, J., Mussons, F. B., and
Aloy, J. F. (2002). Patología neonatal en los menores de 1.500 gramos
con relación al antecedente de corioamnionitis. Anal. Pediatr. 56, 551–555.
doi: 10.1016/S1695-4033(02)77863-6
Gray, P. H., Hurley, T. M., Rogers, Y. M., O’Callaghan, M. J., Tudehope, D. I.,
Burns, Y. R., et al. (1997). Survival and neonatal and neurodevelopmental
outcome of 24–29 week gestation infants according to primary cause
of preterm delivery. Austr. N. Z. J. Obstet. Gynaecol. 37, 161–168.
doi: 10.1111/j.1479-828X.1997.tb02245.x
Hartling, L., Liang, Y., and Lacaze-Masmonteil, T. (2012). Chorioamnionitis
as a risk factor for bronchopulmonary dysplasia: a systematic review
and meta-analysis. Arch. Dis. Child. Fetal Neonatal Ed. 97, F8–F17. .
doi: 10.1136/adc.2010.210187
Harvard Dataverse (2018). Chorioamnionitis and Intraventricular, Hemorrhage,
Studies Included in Systematic Review [Internet]. Available online at:
doi: 10.7910/DVN/J9RHUF
Hendson, L., Russell, L., Robertson, C. M., Liang, Y., Chen, Y., Abdalla, A.,
et al. (2011). Neonatal and neurodevelopmental outcomes of very low birth
weight infants with histologic chorioamnionitis. J. Pediatr. 158, 397–402.
doi: 10.1016/j.jpeds.2010.09.010
Hernández-Díaz, S., Schisterman, E. F., and Hernán, M. A. (2006). The
birth weight “paradox” uncovered? Am. J. Epidemiol. 164, 1115–1120.
doi: 10.1093/aje/kwj275
Higgins, R. D., Saade, G., Polin, R. A., Grobman, W. A., Buhimschi,
I. A., Watterberg, K., et al. (2016). Evaluation and management of
women and newborns with a maternal diagnosis of chorioamnionitis:
summary of a workshop. Obstet. Gynecol. 127, 426–436.
doi: 10.1097/AOG.0000000000001246
Hitti, J., Tarczy-Hornoch, P., Murphy, J., Hillier, S. L., Aura, J., and Eschenbach,
D. A. (2001). Amniotic fluid infection, cytokines, and adverse outcome
among infants at 34 weeks’ gestation or less. Obstet. Gynecol. 98, 1080–1088.
doi: 10.1016/S0029-7844(01)01567-8
Holcroft, C. J., Blakemore, K. J., Allen, M., and Graham, E. M. (2003).
Association of prematurity and neonatal infection with neurologic
morbidity in very low birth weight infants. Obstet. Gynecol. 101, 1249–1253.
doi: 10.1016/S0029-7844(03)00354-5
Inder, T. E., Perlman, J. M., and Volpe, J. J. (2018). Preterm Intraventricular
Hemorrhage/Posthemorrhagic Hydrocephalus Volpe’s Neurology of the Newborn,
6th Edn. Elsevier. Available online at: https://www.sciencedirect.com/book/
9780323428767/volpes-neurology-of-the-newborn
Jackson, C. M., Wells, C. B., Tabangin, M. E., Meinzen-Derr, J., Jobe, A. H., and
Chougnet, C. A. (2017). Pro-inflammatory immune responses in leukocytes of
premature infants exposed to maternal chorioamnionitis or funisitis. Pediatr.
Res. 81, 384–390. doi: 10.1038/pr.2016.232
Kallankari, H., Kaukola, T., Ojaniemi, M., Herva, R., Perhomaa, M.,
Vuolteenaho, R., et al. (2010). Chemokine CCL18 predicts intraventricular
hemorrhage in very preterm infants. Ann. Med. 42, 416–425.
doi: 10.3109/07853890.2010.481085
Kaukola, T., Herva, R., Perhomaa, M., Pääkkö, E., Kingsmore, S., Vainionpää, L.,
et al. (2006). Population cohort associating chorioamnionitis, cord
inflammatory cytokines and neurologic outcome in very preterm,
extremely low birth weight infants. Pediatr. Res. 59, 478–483.
doi: 10.1203/01.pdr.0000182596.66175.ee
Kidokoro, H., Anderson, P. J., Doyle, L. W., Woodward, L. J., Neil, J.
J., and Inder, T. E. (2014). Brain injury and altered brain growth
in preterm infants: predictors and prognosis. Pediatrics 134, e444–e453.
doi: 10.1542/peds.2013-2336
Kim, S. Y., Choi, C. W., Jung, E., Lee, J., Lee, J. A., Kim, H., et al. (2015). Neonatal
morbidities associated with histologic chorioamnionitis defined based on the
site and extent of inflammation in very low birth weight infants. J. Korean Med.
Sci. 30, 1476–1482. doi: 10.3346/jkms.2015.30.10.1476
Kirchner, L., Helmer, H., Heinze, G., Wald, M., Brunbauer, M., Weninger, M.
et al. (2007). Amnionitis with ureaplasma urealyticum or other microbes
leads to increased morbidity and prolonged hospitalization in very low
birth weight infants. Eur. J. Obstet. Gynecol. Reprod. Biol. 134, 44–50.
doi: 10.1016/j.ejogrb.2006.09.013
Klebermass-Schrehof, K., Czaba, C., Olischar, M., Fuiko, R., Waldhoer, T.,
Rona, Z., et al. (2012). Impact of low-grade intraventricular hemorrhage on
long-term neurodevelopmental outcome in preterm infants. Childs Nerv. Syst.
28, 2085–2092. doi: 10.1007/s00381-012-1897-3
Kosuge, S., Ohkuchi, A., Minakami, H., Matsubara, S., Uchida, A., Eguchi, Y., et al.
(2000). Influence of chorioamnionitis on survival and morbidity in singletons
live-born at< 32 weeks of gestation. Acta Obstet. Gynecol. Scand. 79, 861–865.
doi: 10.1034/j.1600-0412.2000.079010861.x
Lau, J., Magee, F., Qiu, Z., Houb,é, J., Von Dadelszen, P., and Lee, S. K.
(2005). Chorioamnionitis with a fetal inflammatory response is associated with
higher neonatal mortality, morbidity, and resource use than chorioamnionitis
displaying a maternal inflammatory response only. Am. J. Obstet. Gynecol. 193,
708–713. doi: 10.1016/j.ajog.2005.01.017
Lee, H. J., Kim, E.-K., Kim, H.-S., Choi, C. W., Kim, B. I., and Choi, J.-H. (2011).
Chorioamnionitis, respiratory distress syndrome and bronchopulmonary
dysplasia in extremely low birth weight infants. J. Perinatol. 31, 166–170.
doi: 10.1038/jp.2010.113
Lee, J. Y., Kim, H. S., Jung, E., Kim, E. S., Shim, G. H., Lee, H. J.,
et al. (2010). Risk factors for periventricular-intraventricular hemorrhage in
premature infants. J. Korean Med. Sci. 25, 418–424. doi: 10.3346/jkms.2010.2
5.3.418
Leviton, A., Kuban, K., and Paneth, N. (2007). Intraventricular haemorrhage
grading scheme: time to abandon? Acta Paediatr. 96, 1254–1256.
doi: 10.1111/j.1651-2227.2007.00379.x
Lim, W., Lien, R., Chiang, M., Fu, R., Lin, J., Chu, S., et al. (2011). Hypernatremia
and grade III/IV intraventricular hemorrhage among extremely low birth
weight infants. J. Perinatol. 31, 193–198. doi: 10.1038/jp.2010.86
Linder, N., Haskin, O., Levit, O., Klinger, G., Prince, T., Naor, N., et al.
(2003). Risk factors for intraventricular hemorrhage in very low birth weight
premature infants: a retrospective case-control study. Pediatrics 111, e590–e5.
doi: 10.1542/peds.111.5.e590
Liu, Z., Tang, Z., Li, J., and Yang, Y. (2014). Effects of placental inflammation
on neonatal outcome in preterm infants. Pediatr. Neonatol. 55, 35–40.
doi: 10.1016/j.pedneo.2013.05.007
Logan, J. W., Westra, S. J., Allred, E. N., O’Shea, T. M., Kuban, K., and Paneth, N.,
et al. (2013). Antecedents of perinatal cerebral white matter damage with
and without intraventricular hemorrhage in very preterm newborns. Pediatr.
Neurol. 49, 88–96. doi: 10.1016/j.pediatrneurol.2013.03.018
Lu, H., Wang, Q., Lu, J., Zhang, Q., and Kumar, P. (2016). Risk factors
for intraventricular hemorrhage in preterm infants born at 34 weeks of
gestation or less following preterm premature rupture of membranes. J.
Stroke Cerebrovasc. Dis. 25, 807–812. doi: 10.1016/j.jstrokecerebrovasdis.2015.
12.011
McAdams, R. M., and Juul, S. E. (2012). The role of cytokines and
inflammatory cells in perinatal brain injury. Neurol. Res. Int. 2012:561494.
doi: 10.1155/2012/561494
McElrath, T. F., Hecht, J. L., Dammann, O., Boggess, K., Onderdonk, A.,
Markenson, G., et al. (2008). Pregnancy disorders that lead to delivery before
the 28th week of gestation: an epidemiologic approach to classification. Am. J.
Epidemiol. 168, 980–989. doi: 10.1093/aje/kwn202
Mehta, R., Nanjundaswamy, S., Shen-Schwarz, S., and Petrova, A. (2006).
Neonatal morbidity and placental pathology. Indian J. Pediatr. 73, 25–28.
doi: 10.1007/BF02758255
Frontiers in Physiology | www.frontiersin.org 15 September 2018 | Volume 9 | Article 1253
Villamor-Martinez et al. Chorioamnionitis and Intraventricular Hemorrhage
Mestan, K., Yu, Y., Matoba, N., Cerda, S., Demmin, B., Pearson, C.,
et al. (2010). Placental inflammatory response is associated with poor
neonatal growth: preterm birth cohort study. Pediatrics 125, e891–e98.
doi: 10.1542/peds.2009-0313
Mitra, S., Aune, D., Speer, C. P., and Saugstad, O. D. (2014). Chorioamnionitis
as a risk factor for retinopathy of prematurity: a systematic review and meta-
analysis. Neonatology 105, 189–199. doi: 10.1159/000357556
Miyazaki, K., Furuhashi, M., Ishikawa, K., Tamakoshi, K., Hayashi, K., Kai, A.,
et al. (2016). Impact of chorioamnionitis on short-and long-term outcomes in
very low birth weight preterm infants: the neonatal research network Japan. J.
Matern. Fetal Neonatal Med. 29, 331–337. doi: 10.3109/14767058.2014.1000852
Mohamed, M. A., and Aly, H. (2010). Transport of premature infants is associated
with increased risk for intraventricular haemorrhage. Arch. Dis. Child Fetal
Neonatal Ed. 95, F403– F407. doi: 10.1136/adc.2010.183236
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., and Group, P. (2009). Preferred
reporting items for systematic reviews and meta-analyses: the PRISMA
statement. PLoS Med. 6:e1000097. doi: 10.1371/journal.pmed.1000097
Molina-Holgado, E., and Molina-Holgado, F. (2010). Mending the broken brain:
neuroimmune interactions in neurogenesis. J. Neurochem. 114, 1277–1290.
doi: 10.1111/j.1471-4159.2010.06849.x
Morales, W. J. (1987). The effect of chorioamnionitis on the developmental
outcome of preterm infants at one year. Obstet. Gynecol. 70, 183–186.
Mu, S.-C., Lin, C.-H., Chen, Y.-L., Ma, H.-J., Lee, J.-S., Lin, M.-I., et al. (2008).
Impact on neonatal outcome and anthropometric growth in very low birth
weight infants with histological chorioamnionitis. J. Formos. Med. Assoc. 107,
304–310. doi: 10.1016/S0929-6646(08)60091-1
Nasef, N., Shabaan, A. E., Schurr, P., Iaboni, D., Choudhury, J., Church, P., et al.
(2013). Effect of clinical and histological chorioamnionitis on the outcome of
preterm infants. Am. J. Perinatol. 30, 059–68. doi: 10.1055/s-0032-1321501
Ogunyemi, D., Murillo, M., Jackson, U., Hunter, N., and Alperson, B. (2003).
The relationship between placental histopathology findings and perinatal
outcome in preterm infants. J. Matern. Fetal Neonatal Med. 13, 102–109.
doi: 10.1080/jmf.13.2.102.109
Oh, K. J., Park, J. Y., Lee, J., Hong, J.-S., Romero, R., and Yoon, B. H. (2018). The
combined exposure to intra-amniotic inflammation and neonatal respiratory
distress syndrome increases the risk of intraventricular hemorrhage in preterm
neonates. J. Perinat. Med. 46, 9–20. doi: 10.1515/jpm-2016-0348
Oh, S.-H., Kim, J.-,j, Do, H.-,j, Lee, B. S., Kim, K.-S., and Kim, E. A.-R. (2015).
Preliminary study on neurodevelopmental outcome and placental pathology
among extremely low birth weight infants. Korean J. Perinatol. 26, 67–77.
doi: 10.14734/kjp.2015.26.1.67
Ohyama, M., Itani, Y., Yamanaka, M., Goto, A., Kato, K., Ijiri, R., et al. (2002). Re-
evaluation of chorioamnionitis and funisitis with a special reference to subacute
chorioamnionitis. Hum. Pathol. 33, 183–190. doi: 10.1053/hupa.2002.31291
Osmanagaoglu, M. A., Ünal, S., and Bozkaya, H. (2005). Chorioamnionitis risk and
neonatal outcome in preterm premature rupture of membranes. Arch. Gynecol.
Obstet. 271, 33–39. doi: 10.1007/s00404-004-0644-8
Pappas, A., Kendrick, D. E., Shankaran, S., Stoll, B. J., Bell, E. F., Laptook,
A. R., et al. (2014). Chorioamnionitis and early childhood outcomes
among extremely low-gestational-age neonates. JAMA Pediatr. 168, 137–147.
doi: 10.1001/jamapediatrics.2013.4248
Park, H. W., Choi, Y. S., Kim, K. S., and Kim, S. N. (2015). Chorioamnionitis
and patent ductus arteriosus: a systematic review and meta-analysis. PLoS ONE
10:e0138114. doi: 10.1371/journal.pone.0138114
Perrone, S., Toti, P., Toti, M. S., Badii, S., Becucci, E., Gatti, M. G.,
et al. (2012). Perinatal outcome and placental histological characteristics: a
single-center study. J. Matern. Fetal Neonatal Med. 25(Supp. 1), 110–113.
doi: 10.3109/14767058.2012.664344
Polam, S., Koons, A., Anwar, M., Shen-Schwarz, S., Hegyi, T. (2005). Effect of
chorioamnionitis on neurodevelopmental outcome in preterm infants. Arch.
Pediatr. Adolesc. Med. 159, 1032–1035. doi: 10.1001/archpedi.159.11.1032
Poralla, C., Hertfelder, H.-J., Oldenburg, J., Müller, A., and Bartmann, P., Heep, A.
(2012). Elevated interleukin-6 concentration and alterations of the coagulation
system are associated with the development of intraventricular hemorrhage in
extremely preterm infants. Neonatology 102, 270–275. doi: 10.1159/000341266
Poryo, M., Boeckh, J. C., Gortner, L., Zemlin, M., Duppr,é, P., Ebrahimi-
Fakhari, D., et al. (2018). Ante-, peri-and postnatal factors associated with
intraventricular hemorrhage in very premature infants. Early Hum. Dev. 116,
1–8. doi: 10.1016/j.earlhumdev.2017.08.010
Pugni, L., Pietrasanta, C., Acaia, B., Merlo, D., Ronchi, A., Ossola, M.
W., et al. (2016). Chorioamnionitis and neonatal outcome in preterm
infants: a clinical overview. J. Matern. Fetal Neonatal Med. 29, 1525–1529.
doi: 10.3109/14767058.2015.1053862
Ramenghi, L. A., Fumagalli, M., Groppo, M., Consonni, D., Gatti, L.,
Bertazzi, P. A., et al. (2011). Germinal matrix hemorrhage: intraventricular
hemorrhage in very-low-birth-weight infants: the independent role of inherited
thrombophilia. Stroke 42, 1889–1893. doi: 10.1161/STROKEAHA.110.5
90455
Revello, R., Alcaide, M. J., Dudzik, D., Abehsera, D., and Bartha, J. L. (2015).
Differential amniotic fluid cytokine profile in women with chorioamnionitis
with and without funisitis. J. Matern. Fetal Neonatal Med. 29, 2161–2165.
doi: 10.3109/14767058.2015.1077512
Richardson, B. S., Wakim, E., and Walton, J. (2006). Preterm histologic
chorioamnionitis: impact on cord gas and pH values and neonatal outcome.
Am. J. Obstet. Gynecol. 195, 1357–1365. doi: 10.1016/j.ajog.2006.03.053
Rivest, S. (2003). Molecular insights on the cerebral innate immune system. Brain
Behav. Immun. 17, 13–19. doi: 10.1016/S0889-1591(02)00055-7
Rocha, G., Proença, E., Quintas, C., Rodrigues, T., and Guimarães, H. (2006).
Chorioamnionitis and neonatal morbidity. Acta Med. Port. 19, 207–212.
Rodríguez-Trujillo, A., Cobo, T., Vives, I., Bosch, J., Kacerovsky,M., Posadas, D. E.,
et al. (2016). Gestational age is more important for short-term neonatal
outcome than microbial invasion of the amniotic cavity or intra-amniotic
inflammation in preterm prelabor rupture of membranes.Acta Obstet. Gynecol.
Scand. 95, 926–933. doi: 10.1111/aogs.12905
Romantsik, O., Bruschettini, M., Calevo, M. G., Banzi, R., and Ley,
D. (2017). Pharmacological pain and sedation interventions for the
prevention of intraventricular hemorrhage in preterm infants on assisted
ventilation - an overview of systematic reviews. Cochrane Libr. CD012706.
doi: 10.1002/14651858.CD012706
Rong, Z., Liu, H., Xia, S., and Chang, L. (2012). Risk and protective factors of
intraventricular hemorrhage in preterm babies in Wuhan, China. Childs Nerv.
Syst. 28, 2077–2084. doi: 10.1007/s00381-012-1875-9
Ryckman, K. K., Dagle, J. M., Kelsey, K., Momany, A. M., and Murray, J. C.
(2011). Replication of genetic associations in the inflammation, complement,
and coagulation pathways with intraventricular hemorrhage in LBW preterm
neonates. Pediatr. Res. 70, 90–95. doi: 10.1203/PDR.0b013e31821ceb63
Salas, A. A., Faye-Petersen, O. M., Sims, B., Peralta-Carcelen, M., Reilly,
S. D., McGwin, G., et al. (2013). Histological characteristics of the fetal
inflammatory response associated with neurodevelopmental impairment
and death in extremely preterm infants. J. Pediatr. 163, 652-7. e2.
doi: 10.1016/j.jpeds.2013.03.081
Sarkar, S., Kaplan, C., Wiswell, T. E., Spitzer, A. R. (2005). Histological
chorioamnionitis and the risk of early intraventricular hemorrhage in infants
born≤ 28 weeks gestation. J. Perinatol. 25, 749–752. doi: 10.1038/sj.jp.7211399
Sato, M., Nishimaki, S., Yokota, S., Seki, K., Horiguchi, H., An, H., et al. (2011).
Severity of chorioamnionitis and neonatal outcome. J. Obstet. Gynaecol. Res.
37, 1313–1319. doi: 10.1111/j.1447-0756.2010.01519.x
Seliga-Siwecka, J. P., and Kornacka, M. K. (2013). Neonatal outcome of
preterm infants born to mothers with abnormal genital tract colonisation
and chorioamnionitis: a cohort study. Early Hum. Dev. 89, 271–275.
doi: 10.1016/j.earlhumdev.2012.10.003
Shankaran, S., Lin, A., Maller-Kesselman, J., Zhang, H., O’shea, T. M., Bada, H. S.,
et al. (2014). Maternal race, demography, and health care disparities impact risk
for intraventricular hemorrhage in preterm neonates. J. Pediatr. 164, 1005-11.
e3. doi: 10.1016/j.jpeds.2014.01.036
Smit, A. L., Been, J. V., Zimmermann, L. J., Kornelisse, R. F., Andriessen, P.,
Vanterpool, S. F., et al. (2015). Automated auditory brainstem response in
preterm newborns with histological chorioamnionitis. J. Matern. Fetal Neonatal
Med. 28, 1864–1869. doi: 10.3109/14767058.2014.971747
Soraisham, A., Trevenen, C., Wood, S., Singhal, N., and Sauve, R. (2013).
Histological chorioamnionitis and neurodevelopmental outcome in preterm
infants. J. Perinatol. 33, 70–75. doi: 10.1038/jp.2012.49
Soraisham, A. S., Singhal, N., McMillan, D. D., Sauve, R. S., Lee, S. K., and
Network, C. N. (2009). A multicenter study on the clinical outcome of
Frontiers in Physiology | www.frontiersin.org 16 September 2018 | Volume 9 | Article 1253
Villamor-Martinez et al. Chorioamnionitis and Intraventricular Hemorrhage
chorioamnionitis in preterm infants. Am. J. Obstet. Gynecol. 200, 372 e1–e6.
doi: 10.1016/j.ajog.2008.11.034
Stanimirovic, D., and Satoh, K. (2000). Inflammatory mediators of cerebral
endothelium: a role in ischemic brain inflammation. Brain Pathol. 10, 113–126.
doi: 10.1111/j.1750-3639.2000.tb00248.x
Strunk, T., Inder, T., Wang, X., Burgner, D., Mallard, C., and Levy, O. (2014).
Infection-induced inflammation and cerebral injury in preterm infants. Lancet
Infect. Dis. 14, 751–762. doi: 10.1016/S1473-3099(14)70710-8
Suarez, R. D., Grobman, W. A., and Parilla, B. V. (2001). Indomethacin tocolysis
and intraventricular hemorrhage. Obstet. Gynecol. 97, 921–925.
Suppiej, A., Franzoi, M., Vedovato, S., Marucco, A., Chiarelli, S.,
and Zanardo, V. (2009). Neurodevelopmental outcome in preterm
histological chorioamnionitis. Early Hum. Dev. 85, 187–189.
doi: 10.1016/j.earlhumdev.2008.09.410
Thomas, W., and Speer, C. P. (2011). Chorioamnionitis: important risk factor
or innocent bystander for neonatal outcome? Neonatology 99, 177–187.
doi: 10.1159/000320170
Tita, A. T., and Andrews, W. W. (2010). Diagnosis and management of clinical
chorioamnionitis. Clin. Perinatol. 37, 339–354. doi: 10.1016/j.clp.2010.02.003
Tortora, D., Severino, M., Malova, M., Parodi, A., Morana, G., Sedlacik, J., et al.
(2017). Differences in subependymal vein anatomy may predispose preterm
infants to GMH–IVH. Arch. Dis. Child Fetal Neonatal Ed. 103,F59–F65.
doi: 10.1136/archdischild-2017-312710
Trevisanuto, D., Peruzzetto, C., Cavallin, F., Vedovato, S., Cosmi, E., Visentin, S.,
et al. (2013). Fetal placental inflammation is associated with poor neonatal
growth of preterm infants: a case-control study. J. Matern. Fetal Neonatal Med.
26, 1484–1490. doi: 10.3109/14767058.2013.789849
Tsiartas, P., Kacerovsky, M., Musilova, I., Hornychova, H., Cobo, T., Sävman, K.,
et al. (2013). The association between histological chorioamnionitis,
funisitis and neonatal outcome in women with preterm prelabor
rupture of membranes. J. Matern. Fetal Neonatal Med. 26, 1332–1336.
doi: 10.3109/14767058.2013.784741
Vaihinger, M., Mazzitelli, N., Balanian, N., and Grandi, C. (2012). The relationship
between placental lesions and early hemorrhagic-ischemic cerebral injury in
very low birth weight infants. Rev. Fac. Cienc. Med. Cordoba 70, 123–133.
van Vliet, E. O., de Kieviet, J. F., van der Voorn, J. P., Been, J. V.,
Oosterlaan, J., and van Elburg, R. M. (2012). Placental pathology and long-
term neurodevelopment of very preterm infants. Am. J. Obstet. Gynecol. 206,
489. e1-e7. doi: 10.1016/j.ajog.2012.03.024
Vergani, P., Locatelli, A., Doria, V., Assi, F., Paterlini, G., Pezzullo, J. C.,
et al. (2004). Intraventricular hemorrhage and periventricular
leukomalacia in preterm infants. Obstet. Gynecol. 104, 225–231.
doi: 10.1097/01.AOG.0000130838.02410.b7
Villamor-Martinez, E., Cavallaro, G., Raffaeli, G., Rahim, O. M. M., Gulden, S.,
Ghazi, A. M., et al. (2018a). Chorioamnionitis as a risk factor for retinopathy
of prematurity: an updated systematic review and meta-analysis. bioRxiv
[Preprint]. doi: 10.1101/291476
Villamor-Martinez, E., Fumagalli, M., Mohammed Rahim, O. M. M., Passera, S.,
Cavallaro, G., Degraeuwe, P., et al. (2018b). Chorioamnionitis is a risk factor
for intraventricular hemorrhage in preterm infants: a systematic review and
meta-analysis. bioRxiv. 1–30. doi: 10.1101/334375
Volpe, J. J. (2015). Impaired neurodevelopmental outcome after mild
germinal matrix-intraventricular hemorrhage. Pediatrics 136, 1185–1187.
doi: 10.1542/peds.2015-3553
Wan, X., Wang, W., Liu, J., and Tong, T. (2014). Estimating the sample mean and
standard deviation from the sample size, median, range and/or interquartile
range. BMCMed. Res. Methodol. 14:135. doi: 10.1186/1471-2288-14-135
Watterberg, K. L., Gerdes, J. S., Gifford, K. L., and Lin, H.-M. (1999). Prophylaxis
against early adrenal insufficiency to prevent chronic lung disease in premature
infants. Pediatrics 104, 1258–1263. doi: 10.1542/peds.104.6.1258
Wilcox, A. J., Weinberg, C. R., and Basso, O. (2011). On the pitfalls of
adjusting for gestational age at birth. Am. J. Epidemiol. 174, 1062–1068.
doi: 10.1093/aje/kwr230
Wirbelauer, J., Thomas, W., and Speer, C. P. (2011). Response of leukocytes
and nucleated red blood cells in very low-birth weight preterm infants after
exposure to intrauterine inflammation. J. Matern. Fetal Neonatal Med. 24,
348–353. doi: 10.3109/14767058.2010.497568
Wu, Y. W., and Colford, J. M. Jr. (2000). Chorioamnionitis as a risk
factor for cerebral palsy: a meta-analysis. JAMA 284, 1417–1424.
doi: 10.1001/jama.284.11.1417
Xu, L. P., Ren, R., Zhu, S., Zhuang, H., Huang, Z., and Yang, H. (2012). Effect of
chorioamnionitis on brain injury in preterm infants. Zhongguo Dang Dai Er Ke
Za Zhi 14, 661–663.
Yamada, N., Sato, Y., Moriguchi-Goto, S., Yamashita, A., Kodama, Y.,
Sameshima, H., et al. (2015). Histological severity of fetal inflammation
is useful in predicting neonatal outcome. Placenta 36, 1490–1493.
doi: 10.1016/j.placenta.2015.10.021
Yanowitz, T. D., Jordan, J. A., Gilmour, C. H., Towbin, R., Bowen, A. D.,
Roberts, J. M., et al. (2002). Hemodynamic disturbances in premature
infants born after chorioamnionitis: association with cord blood cytokine
concentrations. Pediatr. Res. 51, 310–316. doi: 10.1203/00006450-200203000-
00008
Yanowitz, T. D., Potter, D. M., Bowen, A. D., Baker, R. W., and Roberts,
J. M. (2006). Variability in cerebral oxygen delivery is reduced in
premature neonates exposed to chorioamnionitis. Pediatr. Res. 59, 299–304.
doi: 10.1203/01.pdr.0000196738.03171.f1
Yoon, B. H., Romero, R., Kim, C. J., Jun, J. K., Gomez, R., Choi, J. -
H., et al. (1995). Amniotic fluid interleukin-6: a sensitive test for
antenatal diagnosis of acute inflammatory lesions of preterm placenta and
prediction of perinatal morbidity. Am. J. Obstet. Gynecol. 172, 960–970.
doi: 10.1016/0002-9378(95)90028-4
Zanardo, V., Vedovato, S., Suppiej, A., Trevisanuto, D., Migliore, M., Di
Venosa, B., et al. (2008). Histological inflammatory responses in the
placenta and early neonatal brain injury. Pediatr. Dev. Pathol. 11, 350–354.
doi: 10.2350/07-08-0324.1
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 Villamor-Martinez, Fumagalli, Mohammed Rahim, Passera,
Cavallaro, Degraeuwe, Mosca and Villamor. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Physiology | www.frontiersin.org 17 September 2018 | Volume 9 | Article 1253
